# A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco

> **NCT01336660** · PHASE2,PHASE3 · COMPLETED · sponsor: **Instituto Bioclon S.A. de C.V.** · enrollment: 56 (actual)

## Conditions studied

- Poisoning by Scorpion Sting

## Interventions

- **BIOLOGICAL:** Equine F(ab')2 antivenom
- **OTHER:** Intensive care support plus placebo

## Key facts

- **NCT ID:** NCT01336660
- **Lead sponsor:** Instituto Bioclon S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-21
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-12-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336660, "A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01336660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*